Home > Boards > US Listed > Biotechs > Motif Bio plc (MTFB) (MTFB)

got in at 2.62 and will see what

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
nokomis Member Profile
 
Followed By 27
Posts 1,671
Boards Moderated 0
Alias Born 05/20/15
160x600 placeholder
Notice of Effectiveness (effect) Edgar (US Regulatory) - 12/30/2019 6:00:54 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 12/23/2019 4:31:03 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 12/23/2019 4:30:47 PM
Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme... Edgar (US Regulatory) - 12/9/2019 4:46:04 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/27/2019 6:16:24 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/26/2019 6:15:54 AM
Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market GlobeNewswire Inc. - 11/26/2019 2:00:10 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/18/2019 9:10:58 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/15/2019 6:26:43 AM
Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Inno... PR Newswire (US) - 6/7/2019 9:27:00 AM
Motif Bio to Present Iclaprim Data at ASM Microbe 2019 GlobeNewswire Inc. - 5/21/2019 2:00:00 AM
Motif Bio meeting with U.S. FDA held as planned GlobeNewswire Inc. - 5/3/2019 1:25:00 PM
Motif Bio Signs Agreement with Lamellar Biomedical GlobeNewswire Inc. - 5/1/2019 2:00:00 AM
Motif Bio plc: Notice of Annual General Meeting GlobeNewswire Inc. - 4/26/2019 2:01:00 AM
Motif Bio Announces Appointment of Andrew Powell to Board of Directors GlobeNewswire Inc. - 4/26/2019 2:00:00 AM
Motif Bio Presents New Iclaprim Data at ECCMID 2019 GlobeNewswire Inc. - 4/16/2019 2:00:00 AM
Motif Bio Reports Fiscal Year 2018 Results GlobeNewswire Inc. - 4/15/2019 2:00:00 AM
Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology a... PR Newswire (US) - 4/12/2019 10:08:00 AM
Motif Bio to Present Iclaprim Data at ECCMID 2019 GlobeNewswire Inc. - 4/4/2019 2:00:00 AM
Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim GlobeNewswire Inc. - 3/20/2019 3:00:00 AM
Motif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Morgan from the Board GlobeNewswire Inc. - 3/18/2019 3:00:00 AM
Motif Bio Conference Call and Webcast GlobeNewswire Inc. - 2/19/2019 2:00:00 AM
Motif BioSciences Enters into Amendment Agreement with Hercules Capital GlobeNewswire Inc. - 2/18/2019 2:00:00 AM
Motif Bio Receives Complete Response Letter from the FDA GlobeNewswire Inc. - 2/14/2019 2:00:00 AM
nokomis   Wednesday, 03/20/19 02:43:48 PM
Re: $$$MADE post# 5
Post # of 46 
got in at 2.62 and will see what the next hour brings. It's trader action that dictates the price these days. When day traders cash in eod, who knows?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist